Member Info for chrishutch

It looks stronger, have to wait and see but it would not surpise me if we are blue today

Nice amount of buying today!

That*

With only 340m shares in issue and some sticky they would push the price way higher before acquiring enough to make an offer for the company.

They will happen further down the rd in my view.

I mean are owed one or several.

https://t.co/psVf55G4AO

Am I the only one?

morning all

https://www.linkedin.com/posts/leap-gaming_wild-eye-feature-activity-7001476080779841536-fcSp?utm_source=share&utm_medium=member_android

This looks stronger today, be nice to have a blue day. We are owed a few..

Lol

Investee company
@PortageBiotech has created a new drug development model which utilises “a lean structure with many partnerships with academia to keep our fixed costs low and have built a pipeline of 14 assets”
Read more here: http://bit.ly/3EAB6A

https://twitter.com/SEEDInnov/status/1595417692558819329

Just needs a catalyst to get the volume in. With only 231m shares in issue the slightest trade swings it.

Still holding this, it will pop higher one day.

Yep great!

Morning all - very surprised the price is still down here but looking forward to the next push higher. It remains a strong buy for me.

It is one of the reasons I decided to add some more.

Morning Steven, they actually updated us on the cash runway recently. It is now q4 2023

"Taking this action means that existing funds, which would otherwise have been fully utilised by April 2023, will now extend to Q4 2023. Pre-clinical work for OCT130401 will continue, ensuring that Programme 2 is Phase I ready in early 2023. Development work for Programmes 3 and 4 will also continue, with the Company still on target to be at pre-clinical stage (for programme 3) and lead stage (for programme 4) with these programmes by Q2 2023."

They are valued under their current cash and have stated they have a cash runway till Q4 23 if memory serves me correct.